Schistosoma Vaccine to Enter Phase Ib Clinical Trial

“Schistosomiasis ranks among the most devastating poverty related neglected diseases - and a schistosomiasis vaccine would be a game changer both for global public health and poverty reduction,” said Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine. A team of researchers at the George Washington University have received funding from the National Institutes of Health for a Phase Ib clinical trial for a Schistosomiasis vaccine in an endemic area of Brazil. Take a look at this article to read more about the Schistosoma Vaccine.